FDA Inspection 898136 — Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd.
The FDA completed an inspection of Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd. on September 26, 2014 in Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 26, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)